Comparative analysis between centrifuged hematocrit and "point-of-care" hemoglobin: impact on erythropoietin dosing.
The purpose of this CQI project was to examine the degree of anemia among our dialysis population and compare centrifuged hematocrits (HCTs) with point-of-care HemoCue hemoglobin (HGB) for accuracy and to assess any differences in patient outcomes. It was concluded that the point-of-care HemoCue HGB was more accurate than the centrifuged HCT when compared to the laboratory method. It was further concluded that accurate weekly results facilitated more appropriate patient EPO dosages, which in turn influenced patient outcomes.
Marooney
M
M
St. Joseph Hospital Renal Center, Orange, CA, USA.
D000740:Anemia / Q000097:blood* / Q000209:etiology / Q000628:therapy; D015982:Bias; D002498:Centrifugation / Q000592:standards*; D004921:Erythropoietin / Q000008:administration & dosage*; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D019095:Point-of-Care Systems / Q000592:standards*; D015203:Reproducibility of Results; D012189:Retrospective Studies; D017749:Total Quality Management
D006454:Hemoglobins; D004921:Erythropoietin